Here's the live share price of Brooks Laboratories along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Source: Dion Global
Source: Dion Global
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Brooks Laboratories | -2.69 | -27.23 | -36.34 | -53.20 | -64.90 | -7.99 | -11.23 |
| Sun Pharmaceutical Industries | 1.96 | 12.84 | 9.86 | 5.49 | 8.79 | 26.67 | 21.76 |
| Divi's Laboratories | 4.16 | 10.16 | 9.95 | 7.22 | 5.10 | 30.72 | 11.37 |
| Torrent Pharmaceuticals | 1.76 | 6.42 | 5.56 | 19.50 | 34.95 | 38.89 | 26.49 |
| Cipla | 9.13 | 14.74 | 6.09 | -7.62 | -5.48 | 15.46 | 9.30 |
| Dr. Reddy's Laboratories | 5.03 | 8.25 | 4.24 | 6.71 | 9.45 | 14.97 | 4.96 |
| Lupin | 1.80 | -1.81 | 2.61 | 12.91 | 12.70 | 43.47 | 13.62 |
| Zydus Lifesciences | 9.48 | 8.82 | 12.93 | 9.52 | 11.80 | 27.27 | 10.63 |
| Mankind Pharma | 4.21 | 15.58 | 21.59 | 11.44 | -3.23 | 23.01 | 11.71 |
| Aurobindo Pharma | 1.80 | 10.80 | 28.89 | 22.91 | 25.65 | 36.99 | 8.29 |
| Laurus Labs | 6.23 | 19.40 | 32.09 | 36.60 | 121.72 | 62.82 | 22.64 |
| Biocon | 6.93 | 19.94 | 12.51 | 4.92 | 25.90 | 21.16 | 2.16 |
| Glenmark Pharmaceuticals | 6.85 | 8.09 | 19.30 | 30.96 | 67.63 | 56.88 | 31.43 |
| Alkem Laboratories | -0.59 | -2.94 | 1.76 | -4.61 | 2.76 | 18.43 | 12.99 |
| Abbott India | 3.50 | 8.84 | 5.50 | -5.88 | -9.27 | 10.06 | 11.66 |
| Anthem Biosciences | -2.04 | 8.33 | 12.74 | 21.94 | 7.35 | 2.39 | 1.43 |
| Ipca Laboratories | 9.27 | 12.50 | 12.80 | 14.25 | 14.95 | 34.77 | 8.65 |
| Ajanta Pharma | 5.55 | 17.38 | 10.25 | 29.67 | 23.96 | 35.93 | 20.13 |
| GlaxoSmithKline Pharmaceuticals | -2.36 | -1.72 | -7.03 | -5.09 | -15.24 | 22.87 | 10.07 |
| Gland Pharma | 20.12 | 25.32 | 22.46 | 26.92 | 51.52 | 28.06 | -7.56 |
Source: Dion Global
Over the last one year, Brooks Laboratories has declined 64.90% compared to peers like Sun Pharmaceutical Industries (8.79%), Divi's Laboratories (5.10%), Torrent Pharmaceuticals (34.95%). From a 5 year perspective, Brooks Laboratories has underperformed peers relative to Sun Pharmaceutical Industries (21.76%) and Divi's Laboratories (11.37%).
Source: Dion Global
| Day | SMA | EMA |
|---|---|---|
| 5 | 48.2 | 48.65 |
| 10 | 51.22 | 51.32 |
| 20 | 57.44 | 54.98 |
| 50 | 58.62 | 60.1 |
| 100 | 66.13 | 69.87 |
| 200 | 97.52 | 87.33 |
Source: Dion Global
In the latest quarter, Brooks Laboratories remained same as its previous close in promoter holding, while DII stake unchanged at 10.38%, FII holding rose to 0.17%, and public shareholding moved down to 36.84% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Date Time | Announcement |
|---|---|
| May 15, 2026, 12:26 AM IST IST | Brooks Laboratories - Update On Scheme Of Arrangement Involving Brooks Steriscience Limited ('BSL'), A Joint Venture / Associ |
| Apr 30, 2026, 12:27 AM IST IST | Brooks Laboratories - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A |
| Apr 10, 2026, 10:43 PM IST IST | Brooks Laboratories - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Apr 02, 2026, 04:58 PM IST IST | Brooks Laboratories - Reply To Clarification Sought Vide Email Dated 1St April 2026 With Reference To Price Movement. |
| Apr 02, 2026, 01:27 AM IST IST | Brooks Laboratories - Clarification Sought from Brooks Laboratories Ltd |
Source: Dion Global
Brooks Laboratories Ltd. is a Public Limited Listed company incorporated on 23/01/2002 and has its registered office in the State of Himachal Pradesh, India. Company's Corporate Identification Number(CIN) is L24232HP2002PLC000267 and registration number is 000267. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 82.56 Cr. and Equity Capital is Rs. 29.46 Cr. for the Year ended 31/03/2025.
Source: Dion Global
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Brooks Laboratories is ₹48.44 as on May 19, 2026.
The Brooks Laboratories is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Brooks Laboratories is ₹142.69 Cr as on May 19, 2026.
Today’s highest and lowest price of Brooks Laboratories are ₹48.44 and ₹46.14.
The 52-week high/low is the highest and lowest price at which Brooks Laboratories stock has traded in the past 52-week or nearly a year. The 52-week high of Brooks Laboratories is ₹165.95 and 52-week low of Brooks Laboratories is ₹36.90 as on May 19, 2026.
The Brooks Laboratories has shown returns of 4.98% over the past day, -27.23% for the past month, -36.34% over 3 months, -64.9% over 1 year, -7.99% across 3 years, and -11.23% over 5 years.
P/E ratio of and PB ratio of Brooks Laboratories are 6.61 and 1.23 on May 19, 2026. While the company gives a dividend yield of 0.00 per annum.
Source: Dion Global